journal article·2025-06Open access

Supramolecular Nanoplatforms with Activable Ultrasound and Magnetic Resonance Imaging for Cancer Diagnosis and Therapy

Taoxia Liu, Fanqi Liu, Xindi Li, Suying Xu, Leyu Wang

Small· Volume 21· Issue 24

Abstract

Abstract Excellent multifunctional platforms for cancer diagnosis and treatment are highly desirable. Herein, multifunctional nanocomposites are constructed by utilizing Mn 2+ to coordinate to the imidazole moiety anchored on CuO 2 nanoparticles through cyclodextrin‐adamantane interaction. The encapsulated CuO 2 nanoparticles (NPs) can generate hydrogen peroxide (H 2 O 2 ) at tumor sites under acidic conditions upon decomposition, which is further turned into oxygen (O 2 ) under Mn 2+ catalysis, facilitating both ultrasound and magnetic resonance imaging (MRI). Moreover, the proposed nanomedicine enhances reactive oxygen species (ROS) generation and depletes glutathione (GSH), leading to increased lipid peroxidation (LPO) and effective ferroptosis‐mediated cancer therapy. Such a strategy presents a promising approach for the development of theranostics for imaging‐guided tumor therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Chemical Resource Engineering College of Chemistry Beijing University of Chemical Technology Beijing 100029 P. R. China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities

References (50)

Show source-provided references
1. 10.1038/d41586-020-00849-010.1038/d41586-020-00849-0 ↗
2. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
3. 10.1021/acs.chemrev.3c0006210.1021/acs.chemrev.3c00062 ↗
4. 10.1016/j.ccr.2023.21565410.1016/j.ccr.2023.215654 ↗
5. 10.1002/adma.20231216910.1002/adma.202312169 ↗
6. 10.1016/j.ccr.2023.21517810.1016/j.ccr.2023.215178 ↗
7. 10.1039/D2CS00352J10.1039/D2CS00352J ↗
8. 10.1039/D4SC03643C10.1039/D4SC03643C ↗
9. 10.1002/adfm.20221274010.1002/adfm.202212740 ↗
10. 10.1002/smll.20210371210.1002/smll.202103712 ↗
11. 10.1002/smll.20220682110.1002/smll.202206821 ↗
12. 10.1021/acs.nanolett.4c0392910.1021/acs.nanolett.4c03929 ↗
13. 10.1016/j.chempr.2022.06.00610.1016/j.chempr.2022.06.006 ↗
14. 10.1021/acsnano.3c1230510.1021/acsnano.3c12305 ↗
15. 10.1021/acsami.3c1073310.1021/acsami.3c10733 ↗
16. 10.1021/acsami.4c1471510.1021/acsami.4c14715 ↗
17. 10.1016/j.ccr.2024.21630310.1016/j.ccr.2024.216303 ↗
18. 10.1002/smll.20240687910.1002/smll.202406879 ↗
19. 10.1002/adhm.20200154910.1002/adhm.202001549 ↗
20. 10.1039/D4CS00599F10.1039/D4CS00599F ↗
21. 10.1038/s41570-021-00277-210.1038/s41570-021-00277-2 ↗
22. 10.1002/smtd.20170017310.1002/smtd.201700173 ↗
23. 10.1016/j.jconrel.2022.11.02110.1016/j.jconrel.2022.11.021 ↗
24. 10.1186/s40580-021-00287-210.1186/s40580-021-00287-2 ↗
25. 10.1002/adhm.20170051410.1002/adhm.201700514 ↗
26. 10.1021/acsnano.8b0835910.1021/acsnano.8b08359 ↗
27. 10.1021/acsnano.9b0873710.1021/acsnano.9b08737 ↗
28. 10.1016/j.cej.2023.14476610.1016/j.cej.2023.144766 ↗
29. 10.1021/jacs.0c1009810.1021/jacs.0c10098 ↗
30. 10.1021/nn506210a10.1021/nn506210a ↗
31. 10.1002/anie.20090384110.1002/anie.200903841 ↗
32. 10.1002/adfm.20210500110.1002/adfm.202105001 ↗
33. 10.1002/adfm.20160321210.1002/adfm.201603212 ↗
34. 10.1021/acsnano.7b0377210.1021/acsnano.7b03772 ↗
35. 10.1021/acsnano.3c1261510.1021/acsnano.3c12615 ↗
36. 10.1021/acsnano.1c0789310.1021/acsnano.1c07893 ↗
37. 10.1021/acsnano.4c1375310.1021/acsnano.4c13753 ↗
38. 10.1016/j.compositesb.2021.10936410.1016/j.compositesb.2021.109364 ↗
39. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
40. 10.1016/j.nantod.2021.10133710.1016/j.nantod.2021.101337 ↗
41. 10.1021/acsnano.1c0917110.1021/acsnano.1c09171 ↗
42. 10.1016/j.cej.2023.14811310.1016/j.cej.2023.148113 ↗
43. 10.1016/j.carbpol.2020.11687110.1016/j.carbpol.2020.116871 ↗
44. 10.1002/adhm.20230088310.1002/adhm.202300883 ↗
45. 10.1002/smll.20220033010.1002/smll.202200330 ↗
46. 10.1002/adma.20180615810.1002/adma.201806158 ↗
47. 10.1039/D1CS00821H10.1039/D1CS00821H ↗
48. 10.1016/j.ccr.2022.21491910.1016/j.ccr.2022.214919 ↗
49. 10.1002/anie.20231836810.1002/anie.202318368 ↗
50. 10.1021/acs.accounts.3c0023410.1021/acs.accounts.3c00234 ↗